List of Tables
Table 1. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Competitive Situation by Manufacturers in 2024
Table 4. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Point-of-care Testing (POCT) for Cardiovascular Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Point-of-care Testing (POCT) for Cardiovascular Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Point-of-care Testing (POCT) for Cardiovascular Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Point-of-care Testing (POCT) for Cardiovascular Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Point-of-care Testing (POCT) for Cardiovascular Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Cardiovascular Diseases as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Region (2020-2025) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Region (2020-2025)
Table 19. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Region (2026-2031) & (K Units)
Table 20. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Region (2026-2031)
Table 21. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Region (2020-2025)
Table 23. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Region (2026-2031)
Table 25. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2020-2025) & (K Units)
Table 27. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2026-2031) & (K Units)
Table 28. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2020-2025) & (K Units)
Table 32. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2026-2031) & (K Units)
Table 33. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units) by Type (2020-2025)
Table 51. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units) by Type (2026-2031)
Table 52. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Type (2020-2025)
Table 53. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Type (2026-2031)
Table 54. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Type (2020-2025)
Table 57. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Type (2026-2031)
Table 58. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Type (2020-2025)
Table 59. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Type (2026-2031)
Table 60. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units) by Application (2020-2025)
Table 61. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units) by Application (2026-2031)
Table 62. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Application (2020-2025)
Table 63. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Application (2026-2031)
Table 64. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Application (2020-2025)
Table 67. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Application (2026-2031)
Table 68. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Application (2020-2025)
Table 69. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 74. Roche Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Abbott Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 79. Abbott Recent Developments/Updates
Table 80. BioMerieux Company Information
Table 81. BioMerieux Description and Business Overview
Table 82. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. BioMerieux Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 84. BioMerieux Recent Developments/Updates
Table 85. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
Table 86. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Description and Business Overview
Table 87. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 89. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 90. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
Table 91. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
Table 92. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 94. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 95. Getein Biotech, Inc. Company Information
Table 96. Getein Biotech, Inc. Description and Business Overview
Table 97. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Getein Biotech, Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 99. Getein Biotech, Inc. Recent Developments/Updates
Table 100. Sinocare Inc Company Information
Table 101. Sinocare Inc Description and Business Overview
Table 102. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sinocare Inc Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 104. Sinocare Inc Recent Developments/Updates
Table 105. Relia Bioengineering Co., Ltd Company Information
Table 106. Relia Bioengineering Co., Ltd Description and Business Overview
Table 107. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Relia Bioengineering Co., Ltd Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 109. Relia Bioengineering Co., Ltd Recent Developments/Updates
Table 110. Beijing Hotgen Biotech Co.,ltd. Company Information
Table 111. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
Table 112. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 114. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
Table 115. Assure Tech (Hangzhou) Co.,Ltd. Company Information
Table 116. Assure Tech (Hangzhou) Co.,Ltd. Description and Business Overview
Table 117. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 119. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 120. Nanjing Vazyme Biotech Co.,Ltd. Company Information
Table 121. Nanjing Vazyme Biotech Co.,Ltd. Description and Business Overview
Table 122. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Nanjing Vazyme Biotech Co.,Ltd. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 124. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
Table 125. Siemens Healthineers Company Information
Table 126. Siemens Healthineers Description and Business Overview
Table 127. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Siemens Healthineers Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 129. Siemens Healthineers Recent Developments/Updates
Table 130. Danaher Company Information
Table 131. Danaher Description and Business Overview
Table 132. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Danaher Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 134. Danaher Recent Developments/Updates
Table 135. Sansure Biotech Inc. Company Information
Table 136. Sansure Biotech Inc. Description and Business Overview
Table 137. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Sansure Biotech Inc. Point-of-care Testing (POCT) for Cardiovascular Diseases Product
Table 139. Sansure Biotech Inc. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Point-of-care Testing (POCT) for Cardiovascular Diseases Distributors List
Table 143. Point-of-care Testing (POCT) for Cardiovascular Diseases Customers List
Table 144. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Trends
Table 145. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Drivers
Table 146. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Challenges
Table 147. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Point-of-care Testing (POCT) for Cardiovascular Diseases
Figure 2. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share by Type: 2024 & 2031
Figure 4. Based on Immunochromatography Product Picture
Figure 5. Based on Chemiluminescence Technology Product Picture
Figure 6. Based on Biosensor Product Picture
Figure 7. Based on Colloidal Gold Product Picture
Figure 8. Others Product Picture
Figure 9. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share by Application: 2024 & 2031
Figure 11. Hospital
Figure 12. lndependent Testing Organization
Figure 13. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size (2020-2031) & (US$ Million)
Figure 15. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Sales (2020-2031) & (K Units)
Figure 16. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Average Price (US$/Unit) & (2020-2031)
Figure 17. Point-of-care Testing (POCT) for Cardiovascular Diseases Report Years Considered
Figure 18. Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Share by Manufacturers in 2024
Figure 19. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Point-of-care Testing (POCT) for Cardiovascular Diseases Players: Market Share by Revenue in Point-of-care Testing (POCT) for Cardiovascular Diseases in 2024
Figure 21. Point-of-care Testing (POCT) for Cardiovascular Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Country (2020-2031)
Figure 24. North America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Country (2020-2031)
Figure 25. United States Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Country (2020-2031)
Figure 28. Europe Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Country (2020-2031)
Figure 29. Germany Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Region (2020-2031)
Figure 36. China Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Country (2020-2031)
Figure 44. Latin America Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Point-of-care Testing (POCT) for Cardiovascular Diseases Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Point-of-care Testing (POCT) for Cardiovascular Diseases by Type (2020-2031)
Figure 54. Global Revenue Market Share of Point-of-care Testing (POCT) for Cardiovascular Diseases by Type (2020-2031)
Figure 55. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Point-of-care Testing (POCT) for Cardiovascular Diseases by Application (2020-2031)
Figure 57. Global Revenue Market Share of Point-of-care Testing (POCT) for Cardiovascular Diseases by Application (2020-2031)
Figure 58. Global Point-of-care Testing (POCT) for Cardiovascular Diseases Price (US$/Unit) by Application (2020-2031)
Figure 59. Point-of-care Testing (POCT) for Cardiovascular Diseases Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
